Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · IEX Real-Time Price · USD
0.671
-0.060 (-8.21%)
At close: May 1, 2024, 4:00 PM
0.679
+0.008 (1.25%)
After-hours: May 1, 2024, 6:31 PM EDT

Forte Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018201720162015
Market Capitalization
2430213246713164203--
Market Cap Growth
-42.17%-33.49%-93.24%3566.23%-92.22%-19.32%---
Enterprise Value
-13-7-20-10408694125-10-41
PE Ratio
-0.95-0.95-1.51-1.45-10.05-3.13-3.35-5.22--
PS Ratio
------9.084952.36--
PB Ratio
0.690.850.540.767.92-2.672.822.86--
P/FCF Ratio
-1.04-1.04-2.57-1.89-25.36-4.34-4.50-6.39--
P/OCF Ratio
-1.04-1.04-2.57-1.89-25.36-4.60-4.75-6.52--
EV/Sales Ratio
------5.213052.36-209.51-812.49
EV/EBITDA Ratio
0.230.231.450.48-8.80-1.43-2.15-3.410.331.84
EV/EBIT Ratio
0.230.231.450.48-8.79-1.43-2.12-3.380.331.82
EV/FCF Ratio
0.250.252.460.63-22.17-1.98-2.58-3.940.341.95
Debt / Equity Ratio
------0.450.15-0.17-0.19
Debt / EBITDA Ratio
-------0.60-0.29-0.67-0.78
Debt / FCF Ratio
-------0.72-0.34-0.70-0.82
Quick Ratio
10.1310.1312.9323.9226.013.635.815.122.179.93
Current Ratio
10.4610.4613.0624.1926.523.935.915.232.2610.14
Asset Turnover
0000000.2000.00-
Interest Coverage
-------15.13-19.15-15.31-67.01
Return on Equity (ROE)
-94.30%-94.30%-34.70%-45.70%-175.00%-16.90%-92.60%-145.70%30.90%-
Return on Assets (ROA)
-81.40%-81.40%-33.00%-43.30%-142.00%-6.30%-54.50%-45.90%-68.70%-
Return on Capital (ROIC)
-91.99%-91.99%-35.80%-51.71%-78.47%85.22%-54.36%-45.94%30.64%30.66%
Earnings Yield
-128.72%-105.42%-66.09%-68.75%-9.95%-31.93%-29.88%-19.17%--
FCF Yield
-117.75%-96.44%-38.98%-52.82%-3.94%-23.02%-22.24%-15.65%--
Buyback Yield / Dilution
-81.61%-81.61%-24.45%-89.81%-249.05%-57.65%-37.32%-563.99%-0.82%-
Total Shareholder Return
-81.61%-81.61%-24.45%-89.81%-249.05%-57.65%-37.32%-563.99%-0.82%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).